Navigation Links
Kessler Foundation awarded Department of Defense grant for spinal cord injury research

West Orange, NJ. April 16, 2014. Kessler Foundation has been named awardee of a three-year grant for $1.8 million from the Department of Defense Spinal Cord Injury Research Program. Gail Forrest, PT, PhD, is principal investigator for the randomized, double-blinded, controlled, multi-site clinical trial, which will test strategies to improve bone and muscle strength after spinal cord injury. Dr. Forrest is assistant director of Human Performance & Engineering Research at Kessler Foundation. Two additional sites will participate - the University of Louisville-Frazier Rehab and the James J. Peters VA Medical Center, Bronx, New York. The study is slated to begin in the fall of 2014.

"We are pleased to share our decades of experience in spinal cord injury research to address the critical need for interventions to improve health and quality of life for individuals with SCI," said Rodger DeRose, president and CEO of Kessler Foundation. "Together with our collaborators, we have confidence that safe and effective solutions will be developed that minimize secondary complications of spinal cord injury."

Within the first six months of spinal cord injury, rapid wasting of the muscle and bone occurs in the lower limbs, often resulting in osteoporosis. Many men also experience significant declines in serum testosterone levels. "These lead to further complications," noted Dr. Forrest, "including elevated risks for fractures, weight gain, cardiovascular disease, urinary tract infection, and pressure ulcers all of which adversely affect quality of life, and raise the costs of care. This is why developing interventions to address bone and muscle loss is so important."

Kessler Foundation proposes a three-armed intervention strategy for treating muscle and bone called the "Activity-Dependent Rehabilitation Model" combination therapy with stand training, testosterone replacement therapy, and electrical stimulation. This strategy is likely to yield interventions readily transferable to clinical care," said Dr. Forrest.

Across the three sites, 56 men with subacute to chronic SCI and low testosterone levels will be enrolled and randomized into one of 4 groups: 1) Stand Training only; 2) Stand+Electrical Stimulation; 3) Stand Training+ Testosterone; 4) Stand Training+Testosterone+Electrical stimulation. Each research participant will complete 60 sessions of training.


Contact: Carolann Murphy
Kessler Foundation

Related biology news :

1. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
2. Kessler Foundation awarded more than $1.2 million in grants by the NJ Commission on Sci Research
3. Kessler Foundation neuroimaging study sheds light on mechanisms of cognitive fatigue in MS
4. Kessler Foundation researchers study impact of head movement on fMRI data
5. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
6. John A. Kaufman named 2012 Dotter Lecturer by Society of Interventional Radiology Foundation
7. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
8. 2012 ACMG Foundation/Signature Genomic Laboratories Travel Award winner announced
9. ASBMB wins National Science Foundation grant to enhance K-12 science education
10. UF receives $1 million from Keck Foundation to study mechanisms of inherited disease
11. Merkin Family Foundation to fund next generation of Broad Institute scientists
Post Your Comments:
Related Image:
Kessler Foundation awarded Department of Defense grant for spinal cord injury research
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
(Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight Medical ... to the healthcare market. The company's primary focus is on new product introductions, ... strategies that are necessary to help companies efficiently bring their products to market. ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
Breaking Biology Technology: